Premium
Hemab Therapeutics Holdings Inc (COAG)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
Hemab Therapeutics Holdings, Inc. operates as a clinical-stage biotechnology company developing therapies that reimagine the treatment of blood coagulation disorders to sustain life and human resilience in United States of America and Denmark. Its products includes (HMB-001), is a bispecific antibod... Hemab Therapeutics Holdings, Inc. operates as a clinical-stage biotechnology company developing therapies that reimagine the treatment of blood coagulation disorders to sustain life and human resilience in United States of America and Denmark. Its products includes (HMB-001), is a bispecific antibody currently in Phase 1/2 clinical development for the prophylactic treatment of Glanzmann thrombasthenia and Phase 2 clinical development for the prophylactic treatment of Factor VII deficiency; and second clinical-stage asset, HMB-002, is a monovalent antibody in Phase 1/2 clinical development for the subcutaneous prophylactic treatment of Von Willebrand disease. It also advances multiple preclinical and discovery-stage assets. The company was founded in 2020 and is based in Cambridge, Massachusetts. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 3.12 | 10.6666666667 | 29.25 | 32.4 | 27.4725 | 241289 | 29.86228139 | CS |
| 4 | 4.67 | 16.8592057762 | 27.7 | 32.4 | 23.8065 | 283374 | 27.69444999 | CS |
| 12 | 1.5 | 4.85908649174 | 30.87 | 32.4 | 23.0001 | 259402 | 27.01616818 | CS |
| 26 | 1.5 | 4.85908649174 | 30.87 | 32.4 | 23.0001 | 259402 | 27.01616818 | CS |
| 52 | 1.5 | 4.85908649174 | 30.87 | 32.4 | 23.0001 | 259402 | 27.01616818 | CS |
| 156 | 1.5 | 4.85908649174 | 30.87 | 32.4 | 23.0001 | 259402 | 27.01616818 | CS |
| 260 | 1.5 | 4.85908649174 | 30.87 | 32.4 | 23.0001 | 259402 | 27.01616818 | CS |
Transactions différées
Pour obtenir des transactions en temps réel, améliorez votre compte
Passer à la version en temps réel| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
